QCMA
BMY icon

Quad Capital Management Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Quad Capital Management Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-60,000
Closed -$3.04M – 17
2019
Q3 		$3.04M Buy
+60,000
New +$2.82M 1.52% 14

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quad Capital Management Advisors's BMY Position: Q4 2019 in Review

Quad Capital Management Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 60,000 shares — an estimated $3.04M sold.

Quad Capital Management Advisors first reported a position in BMY in Q3 2019 and held it in 1 quarter. The position peaked at $3.04M in Q3 2019. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Quad Capital Management Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • Quad Capital Management Advisors sold 60,000 Bristol-Myers Squibb shares in Q4 2019, an estimated $3.04M.
  • Quad Capital Management Advisors first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 1 quarter.
  • Quad Capital Management Advisors's Bristol-Myers Squibb position peaked at $3.04M in Q3 2019.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Quad Capital Management Advisors's 13F filing for Q4 2019, filed 9 Jan 2020.